INBX - Balance Sheet - Inhibrx Biosciences, Inc.

Current Liabilities	40.7 M
Accounts Payable	9.24 M
Short-Term Debt	1.6 M
Other Current Liabilities	29.9 M
Non-Current Liabilities	6.45 M
Long-Term Debt	0
Other Non-Current Liabilities	6.45 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	152.6	277.9	273.9	131.3	128.7	11.5	2.1	13.5	20.0
Short Term Investments	0	0	0	0	0	0	0	0	0
Receivables	0.4	0.8	0.3	0.9	0.6	0.4	0.7	0.7	0
Inventory	0	0	(0.3)	(0.9)	(129.3)	3.2	2.3	1.0	0
Other Current Assets	0.8	16.7	5.5	7.8	132.2	0.4	0.6	0.3	0.4
Total Current Assets	160.4	295.4	280.5	139.1	132.2	15.6	5.7	15.4	20.4
PP&E	13.5	9.4	7.2	9.5	11.3	10.7	2.6	1.8	0.9
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0
Other Long Term Assets	6.8	3.2	3.2	1.8	0.2	0.2	1.7	0	1
Other Assets	0	0	0	0	0	0	0	0	1
Total Assets	180.8	307.9	290.9	150.4	143.7	26.5	10.0	17.2	21.3
LIABILITIES
Accounts Payable	9.2	8.3	4.3	9.1	13.5	3.1	6.5	0.8	0.2
Short Term Debt	1.6	4.1	3.7	1.7	1.5	4.7	5.9	5.2	4.3
Other Current Liabilities	29.9	43.9	19.3	9.6	13.4	4.8	2.1	0.4	0.9
Total Current Liabilities	40.7	56.3	27.6	22.5	31.4	20.6	16.2	8.9	5.3
Long Term Debt	0	208.1	205.2	70.5	36.0	37.1	3.6	9.5	14.7
Deferred Tax Income	0	0	0	(0.1)	0	0	0	0	0
Other Liabilities	0	0	0	5.1	0.2	61.4	47.9	21.3	92 K
Total Liabilities	47.2	264.4	232.8	98.1	68.3	120.1	67.6	39.7	20.0
EQUITY
Common Stock	1 K	5 K	4 K	4 K	4 K	2 K	3 K	0	0
Retained Earnings	(106.1)	(613.7)	(372.4)	(227.1)	(145.4)	(69.3)	(17.9)	(28.8)	(9.2)
Other Accumulative Comprehensive Income/Loss	0	0	0	(150.4)	(143.7)	(59.5)	(1.7)	(1.0)	0
Total Equity	133.6	43.5	58.1	52.4	75.5	(93.6)	(57.6)	(22.4)	1.2
Total Liabilities and Equity	180.8	307.9	290.9	150.4	143.7	26.5	10.0	17.2	21.3
SHARES OUTSTANDING
Common Shares Outstanding	14.5	47.1	40.1	38.0	25.3	36.6	27.1	28.8	36.6

Free